The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective

Health Economics Review

Table 3 Results of the logistic regression model for predictors of hospitalisation

Variable	Regression Coefficient(Log Odds Ratio)	Standard Error	Odds Ratio	95%-Odds Ratio Confidence-Interval	p-value
Age	−0.038	0.003	0.962	(0.958,0.967)	<0.001
Gender
Male
Female	0.179	0.062	1.196	1.058-1.351	0.004
Drug groups
No relevant outpatient drug prescriptions
Atypical antipsychotics (non-switcher)	−1.362	0.088	0.256	(0.216,0.305)	<0.001
Atypical antipsychotics (switcher)	−0.645	0.126	0.524	0.409-0.672	<0.001
Atypical antipsychotics with adjuvant therapy	−0.839	0.126	0.432	0.337-0.553	<0.001
Typical antipsychotics (non-Switcher)	−1.366	0.125	0.255	0.200-0.326	<0.001
Typical antipsychotics (switcher)	−0.762	0.175	0.467	0.331-0.657	<0.001
Typical and atypical antipsychotics	−0.376	0.136	0.686	0.526-0.896	0.006
Depot neuroleptics	0.198	0.105	1.219	0.993-1.497	0.058
Continuously drug treatment	−0.657	0.073	0.519	0.450-0.598	<0.001
Number of doctor visits	−0.008	0.001	0.992	0.990-0.995	<0.001
Rehabilitation	0.734	0.372	2.084	1.006-4.318	0.048
Inability to work episode of more than six weeks	0.200	0.146	1.221	0.917-1.627	0.172
Hospital treatment in 2004	0.739	0.084	2.093	1.777-2.466	<0.001
Co-morbid substance abuse (ICD F10-F19)	0.278	0.081	1.320	1.125-1.548	0.001

ISSN: 2191-1991